08:34 AM EDT, 04/04/2024 (MT Newswires) -- HEALWELL AI Inc. , an AI and data science company focused on preventative care, which saw its shares drop 6% yesterday, said Thursday that its subsidiary Pentavere Research Group has published a paper that validates the use of generative artificial intelligence to identify rare lung cancer patients.

According to a statement, the peer-reviewed paper utilizes AI and large language models to identify rare lung cancer patients using real-world electronic health record data and supporting precision oncology efforts.

"Pentavere is pushing the boundaries of innovation in healthcare and leveraging AI to address the most pressing challenges facing patients and healthcare providers," Aaron Leibtag, CEO of Pentavere, said. "We have harnessed this capability into very productive work with world leading pharma and cancer centers to help optimize patient care in lung cancer. We've developed best in class AI that is core to our mission of preventative care. This paper highlights our ability to use generative AI in the real world to unlock key clinical and commercial value."